跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

T-047

Supelco

(±)-Δ9-四氢大麻酚标准液 溶液

100 μg/mL in heptane, ampule of 1 mL, Cerilliant®

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C21H30O2
CAS号:
6465-30-1
分子量:
314.46
EC號碼:
205-563-8
分類程式碼代碼:
41116107
NACRES:
NA.24

形狀

liquid

特點

Snap-N-Spike®/Snap-N-Shoot®

包裝

ampule of 1 mL

製造商／商標名

Cerilliant®

drug control

Narcotic Licence Schedule D (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

濃度

100 μg/mL in heptane

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

cannabis testing
cannabis testing

形式

single component solution

儲存溫度

−20°C

SMILES 字串

O1C(C2C(c3c1cc(cc3O)CCCCC)C=C(CC2)C)(C)C

InChI

1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3

InChI 密鑰

CYQFCXCEBYINGO-UHFFFAOYSA-N

相关类别

一般說明

(±)-Δ9-THC是大麻的主要活性成分和主要精神活性大麻素。除持续非法使用外，该药还适合治疗厌食症和恶心，以商品名Marinol®出售。该Certified Spiking Solution®适合用作从法医分析和临床毒理学研究到尿液药物检测的各种LC/MS或GC/MS应用的校准品或对照品的起始材料。

其他說明

仅供定量使用

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Marinol is a registered trademark of Unimed Pharmaceuticals, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相關產品

产品编号
说明
价格

C-115

Cannabinol-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-026

(±)-11-羟基-Δ9-四氢大麻酚标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-027

(±)-11-羟基-Δ9-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-041

(±)-11-Hydroxy-Δ9-THC-D3 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-003

−-Δ9-四氢大麻酚-D3标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-004

(±)-11-nor-9-羧基-Δ9-四氢大麻酚-D3标准液 CRM 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-005

(−)-Δ9-四氢大麻酚标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-006

(±)-Δ-四氢大麻酸标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-007

(±)-11-nor-9-Carboxy-Δ9-THC-D9 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-008

(±)-11-nor-9-羧基-Δ9-四氢大麻酚-D3标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-011

−-Δ9-四氢大麻酚-D3标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-018

(−)-11-nor-9-羧基-Δ9-THC 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-019

(−)-11-nor-9-羧基-Δ9-THC 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-038

(+)-11-去甲-Δ9-THC-9-羧酸葡糖苷酸 溶液, 100 μg/mL in methanol, ampule of 1 mL, Cerilliant®

T-080

(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 glucuronide solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

T-159

(6aR, 9S)-delta10-THC solution, 1 mg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

T-171

(6aR, 9R)-delta10-THC solution, 1 mg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

H-166

11-Nor-9beta-hydroxyhexahydrocannabinol (11-Nor-9beta-HHC) solution, 1 mg/mL (Acetonitrile (Degas)), certified reference material, ampule of 1 mL, Cerilliant®

T-158

(-)-11-nor-9-Carboxy-Delta8-THC-D3 solution, 100 μg/mL (Degassed Methanol), certified reference material, ampule of 1 mL, Cerilliant®

H-165

Hexahydrocannabinol (HHC) solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

訊號詞

Danger

危險分類

Aquatic Acute 1 - Aquatic Chronic 1 - Asp. Tox. 1 - Flam. Liq. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Central nervous system

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 2

閃點（°F）

24.8 °F - closed cup

閃點（°C）

-4 °C - closed cup

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

David R Maguire et al.
The Journal of pharmacology and experimental therapeutics, 345(3), 354-362 (2013-03-29)
Cannabinoid receptor agonists enhance the antinociceptive effects of μ-opioid receptor agonists, which suggests that combinations of these drugs might enhance therapeutic effectiveness (e.g., analgesia). However, it is not clear whether combinations of these drugs also enhance abuse or dependence liability.
Suspected dronabinol withdrawal in an elderly cannabis-naive medically ill patient.
Russ S Muramatsu et al.
The American journal of psychiatry, 170(7), 804-804 (2013-07-04)
M Waldman et al.
Biochemical pharmacology, 85(11), 1626-1633 (2013-03-30)
Tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is a cannabinoid agonist that exerts its effects by activating at least two specific receptors (CB1 and CB2) that belong to the seven transmembrane G-protein coupled receptor (GPCR) family. Both CB1 and
Erik T Garbacik et al.
Journal of biomedical optics, 18(4), 046009-046009 (2013-04-17)
Nature has developed many pathways to produce medicinal products of extraordinary potency and specificity with significantly higher efficiencies than current synthetic methods can achieve. Identification of these mechanisms and their precise locations within plants could substantially increase the yield of
S Ameur et al.
Analytical and bioanalytical chemistry, 405(10), 3117-3123 (2013-01-29)
A cloud point extraction coupled with high performance liquid chromatography (HPLC/UV) method was developed for the determination of Δ(9)-tetrahydrocannabinol (THC) in micellar phase. The nonionic surfactant "Dowfax 20B102" was used to extract and pre-concentrate THC from cannabis resin, prior to
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门